Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.33 |
| ▸ | CA2 | P00918 | 3/20 | 0.33 |
| ▸ | CA9 | Q16790 | 3/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2058392 | 0.86 | — | — | |
| SCHEMBL1009974 | 0.82 | CA12 (0.36) | CA12CA2CA9CA1ALDH1A1 | |
| SCHEMBL27827738 | 0.81 | CA12 (0.33) | CA12CA2CA9CA1ALDH1A1 | |
| SCHEMBL7761377 | 0.78 | DNM1 (0.46) | CA12CA2CA9CA1ALDH1A1 | |
| SCHEMBL7758120 | 0.78 | DNM1 (0.46) | CA12CA2CA9CA1ALDH1A1 | |
| SCHEMBL7754975 | 0.78 | DNM1 (0.46) | CA12CA2CA9CA1ALDH1A1 | |
| SCHEMBL7759643 | 0.78 | DNM1 (0.46) | CA12CA2CA9CA1ALDH1A1 | |
| SCHEMBL7754962 | 0.78 | DNM1 (0.46) | CA12CA2CA9CA1ALDH1A1 | |
| SCHEMBL98702 | 0.75 | CA12 (0.33) | CA12CA2CA9CA1ALDH1A1 | |
| SCHEMBL1145187 | 0.75 | MAPT (0.40) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111607288-A | Casein type water-based pigment yellow ink-jet ink for titanium white paper and preparation method thereof | 杭州华大海天科技有限公司 | 2020-09-01 | — | — | CN | claimed |
| WO-2021001727-A1 | SOLUTION PROCESSABLE METAL-ORGANIC FRAMEWORKS VIA SURFACE FUNCTIONALIZATION | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2021-01-07 | — | — | WO | disclosed |
| US-20200384115-A1 | TARGETED DELIVERY TO BETA CELLS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2020-12-10 | — | — | US | disclosed |
| CN-111607288-A | Casein type water-based pigment yellow ink-jet ink for titanium white paper and preparation method thereof | 杭州华大海天科技有限公司 | 2020-09-01 | — | — | CN | disclosed |
| US-8277776-B2 | Compositions for delivery of therapeutics and other materials | PHARMAIN CORPORATION (US) | 2012-10-02 | — | — | US | disclosed |
| US-8257682-B2 | Compositions for delivery of therapeutics and other materials | PHARMAIN CORPORATION (US) | 2012-09-04 | — | — | US | disclosed |
| US-8231859-B2 | Compositions for delivery of therapeutics and other materials | PHARMAIN CORPORATION (US) | 2012-07-31 | — | — | US | disclosed |
| EP-1478406-B1 | COMPOSITIONS FOR DELIVERY OF THERAPEUTICS AND OTHER MATERIALS, AND METHODS OF MAKING AND USING THE SAME | PHARMAIN CORP (US) | 2011-01-05 | — | — | EP | disclosed |
| US-7790140-B2 | Compositions for delivery of therapeutics and other materials, and methods of making and using the same | PHARMAIN CORPORATION (US) | 2010-09-07 | — | — | US | disclosed |
| US-20100221184-A1 | Compositions for Delivery of Therapeutics and Other Materials | PHARMAIN CORPORATION | 2010-09-02 | — | — | US | disclosed |
| US-6111044-A | CONTAINS A RESIN HAVING AT LEAST ONE FUNCTIONAL GROUP SELECTED FROM THE GROUP CONSISTING OF A BLOCKED HYDROXYL GROUP, BLOCKED CARBOXYLIC ACID, AND AN EPOXY GROUP | NOF CORPORATION (JP) | 2000-08-29 | — | — | US | disclosed |
| WO-1999051546-A9 | PARALLEL COMBINATORIAL APPROACH TO THE DISCOVERY AND OPTIMIZATION OF CATALYSTS AND USES THEREOF | HARVARD COLLEGE (US) | 1999-11-18 | — | — | WO | disclosed |
| WO-1999051546-A1 | PARALLEL COMBINATORIAL APPROACH TO THE DISCOVERY AND OPTIMIZATION OF CATALYSTS AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1999-10-14 | — | — | WO | disclosed |
| US-5660937-A | CURABLE HEAT SENSITIVE MIXTURE COATINGS COMPRISING ONE OR TWO UNSATURATE ESTER COMPOUNDS WITH ETHER OR THIOETHER GROUP, THERMAL LATENT ACID CATALYST; STORAGE STABILITY, ACID RESISTANCE, WEATHERPROOFING; CLEAR COATINGS, OVERCOATINGS | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1997-08-26 | — | — | US | disclosed |
| EP-0535667-B1 | Thermosetting compositions, method of coating and coated articles | NIPPON OILS & FATS CO LTD (JP) | 1997-08-20 | — | — | EP | disclosed |
| US-5549932-A | WEATHERPROOFING, STORAGE STABILITY | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1996-08-27 | — | — | US | disclosed |
| US-5521011-A | Thermosetting compositions, thermal latent acid catalysts, methods of coating and coated articles | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1996-05-28 | — | — | US | disclosed |
| EP-0709415-A2 | Curable base-coat composition, method of film-forming and coated articles | NOF CORPORATION (JP) | 1996-05-01 | — | — | EP | disclosed |
| US-5419929-A | Acid resistant coatings and weather resistant coatings | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1995-05-30 | — | — | US | disclosed |
| EP-0535667-A2 | Thermosetting compositions, thermal latent acid catalysts, method of coating and coated articles | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1993-04-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200384115-A1 | TARGETED DELIVERY TO BETA CELLS | IAPP, ZFR, ZC3H11A | CA12 2957/4885CA2 3172/4885CA9 3348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.